weight loss

The recent arrival of generic semaglutide – the active ingredient in popular diabetes and weight-loss drugs – is poised to reshape the …

The GLP-1 Cliff Edge: Why Maintaining Weight Loss May Require Lifelong Medication A startling statistic is emerging from recent studies: individuals who …

Beyond Diabetes: GLP-1s Poised to Redefine Cardiovascular & Renal Health Nearly 1.4 million Americans are living with Type 1 diabetes, and for …

The Rising Tide of Wedding Weight Loss: How GLP-1s are Changing the Bridal Landscape The pursuit of a “perfect” wedding day often …

Nearly 40% of individuals regaining weight after discontinuing GLP-1 receptor agonists experienced a significantly elevated risk of major adverse cardiovascular events (MACE) …

The race to conquer obesity is entering a new phase, one where simply shedding pounds isn’t enough. Swedish biotech Atrogi has begun …

Black Bean Breakthrough: Could This Humble Legume Reshape the Future of Food-as-Medicine? Over 40% of American adults are now considered obese, a …

Beyond Weight Loss: Could GLP-1 Drugs Usher in a New Era of Mental Wellbeing? Nearly 280 million people globally live with depression, …

Weight-Loss Drugs Under Scrutiny: Health Risks Rise as Demand Surges A growing wave of concerns is emerging surrounding the widespread use of …

Beyond the Scale: How Neurobiology and Personalized Approaches Will Define the Future of Obesity Treatment Nearly 40% of adults worldwide are living …